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A B S T R A C T
Mitochondrial dysfunction and inﬂammation contribute to the initiation and development of several brain pa-
thological conditions, including Alzheimer’s disease and cerebral ischemia. Linalool is an aromatic plant-derived
monoterpene alcohol with reported anti-inﬂammatory, and anti-oxidant properties. We investigated the role of
linalool on glutamate-induced mitochondrial oxidative stress in immortalized neuronal HT-22 cells. Glutamate
induced oxidative stress in neuronal cells, as detected by real-time cell impedance measurements, MTT assay,
and analysis of Annexin V/PI. Administration of linalool 100 μM reduced cell death mediated by glutamate.
Staining of glutamate-stimulated mitochondria by MitoTracker revealed improved morphology in the presence
of linalool. Furthermore, we demonstrated a potential neuroprotective eﬀect of linalool in conditions of oxi-
dative stress by a reduction of mitochondrial ROS and mitochondrial calcium levels, and by preserving mi-
tochondrial membrane potential. Experiments using both high-resolution respirometry and Seahorse
Extracellular ﬂux analyzer showed that linalool was able to promote an increase in uncoupled respiration that
could contribute to its neuroprotective capacity. Linalool protection was validated using organotypic hippo-
campal slices as ex vivo model with NMDA as a stimulus to induce excitotoxity cell damage. These results
demonstrate that linalool is protective in an in vitromodel of glutamate-induced oxidative stress and in an ex-vivo
model for excitotoxity, proposing linalool as a potential therapeutic agent against neurodegenerative brain
diseases where oxidative stress contributes to the pathology of the disease.
1. Introduction
Oxytosis is a non-apoptotic form of cell death associated with in-
creased oxidative stress and, according to recent ﬁndings, also with
mitochondrial dysfunction [1,2]. The term oxytosis was ﬁrst introduced
on the basis of ﬁndings on oxidative cell death in neuronal cells [3].
Oxytosis is characterized by both cellular and mitochondrial ROS ac-
cumulation [4]. Emerging evidence links oxytosis cell death to the ﬁeld
of neuroscience with increasing indication for its contribution to brain
injury and degeneration [5]. For example, oxytosis cell death me-
chanisms contribute to the pathology of many age-associated neuro-
degenerative diseases such as Alzheimer disease (AD) or acute events
such as cerebral ischemia, where elevated production of reactive
oxygen species (ROS) and reactive nitrogen species (RNS), causes da-
mage to all components of the cell, including proteins, lipids, and DNA
[6–8].
Oxytosis-induced cell death can be initiated by compounds in-
hibiting the cysteine/glutamate antiporter system (xc−), such as glu-
tamate [3,9–11]. Blockage of the xc− system by excessive extracellular
glutamate prevents the import of cystine, thereby reducing substrate
availability for glutamate cysteine ligase (GCL), leading to depletion of
intracellular glutathione (GSH) and decreased activity of glutathione
peroxidase 4 (GPX4) [5]. GSH plays an essential role in several phy-
siological processes acting directly as a co-factor in enzymatic reactions
or indirectly as the major thiol-disulﬁde redox buﬀer in all mammalian
cells. These properties allow GSH to provide a cellular critical defense
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system against many forms of cellular stress, in particular, oxidative
stress [12]. Reduced levels of cystine, in response to excessive gluta-
mate application, leads to a depletion of GSH, GPX4 inhibition, and
lipid peroxide formation. These events result in an increase of mi-
tochondrial and cellular ROS levels, resulting in cell death.
Glutamate-mediated oxidative stress mechanisms have been ex-
tensively studied in HT-22 cells, a subclone of the hippocampal cell line
HT4 [13]. This neuronal cell line has been speciﬁcally selected for its
sensitivity to glutamate. Exposure of neuronal HT-22 cells to toxic
concentrations of glutamate initiates a well-deﬁned signaling cascade
which mediates cell death through inhibition of xc− GSH depletion,
excessive ROS production and mitochondrial damage [5]. Recent evi-
dence supports that natural compounds (monoterpenes) might prevent
oxidative stress, pathological features of neurodegenerative diseases
and of acute events such as stroke [14,15]. Linalool, an enantiomer of
the naturally occurring, aromatic plant-derived (e.g. Lavandula angu-
stifolia, Melissa oﬃcinalis, Rosmarinus oﬃcinalis, and Cymbopogon ci-
tratus) monoterpene alcohol is a major component of essential oils [16].
Linalool exhibits several eﬀects on the CNS, serving as antinociceptive,
anticonvulsant, anxiolytic, and sedative agent [17–19]. Furthermore,
various pharmacological properties such as antimicrobial, anti-inﬂ-
ammatory, antileishmanial, anti-atherogenic, and anti-depressant eﬀ
;ects have been reported [20–25]. Antioxidant properties of linalool
were also demonstrated in a study, investigating oxidation reactions in
unsaturated fatty acids extracted from guinea pig brains challenged
with H2O2 to induce oxidative stress [26].
We have recently shown linalool being protective in neurodegen-
erative diseases, and being able to reduce the histopathological mar-
kers, including amyloid plaques and tau hyperphosphorylation in a
triple transgenic mice model of AD (3xTg-AD) with improvements in
behavioral assessments of learning and spatial memory [27]. Besides, in
an in vitro model of glutamate excitotoxicity, we found that linalool
protected neurons and astrocytes as indicated by reduced lactate de-
hydrogenase (LDH) release as well as recovered cellular ATP levels, a
marker of improved mitochondrial functions. Moreover, neurological,
motor, and cognitive impairments were ameliorated by oral linalool
administration following global ischemia [28].
Linalool has been shown protective in several models of neurode-
generation, however, the mechanisms underlying the neuroprotective
eﬀ ;ect of linalool in relation to mitochondrial functions still remain
elusive and additional research is necessary in order to determine its
precise eﬀ ;ects.
Our goal was to evaluate the eﬀect of linalool on the physiological
function of mitochondria and its potential neuroprotective properties in
conditions of glutamate-induced oxytosis in HT-22 cells and in ex vivo
organotypic hippocampal slices.
2. Materials and methods
2.1. Cell culture
HT-22 cells (kindly provided by Prof. Culmsee), which were used to
model neurons, were cultured in Dulbecco’s modiﬁed Eagle Medium
(DMEM; Life Technologies, UK, #42340-025) supplemented with 10%
fetal bovine serum (FBS; GE Healthcare Life Sciences, Utah, USA,
#SV30160.03), 100 U/mL penicillin, 100 μg/mL streptomycin (Gibco;
Life Technologies, USA, #15070-063) and 1% sodium pyruvate (Gibco,
Life Technologies Corporation, USA, #11360-070) at 37 °C and 5%
CO2. The passage number used were between 200-250 and the cells
were mycoplasma negative. Additional substances used were linalool
(Sigma-Aldrich Chemie GmbH, Steinheim, Germany, #L2602, Lot#
STBG7505), and glutamate (Sigma-Aldrich Chemie GmbH, Steinheim,
Germany, #G1626, Lot#slbl6389 V).
2.2. Cell viability assay and xCELLigence measurement
Cell viability and metabolic activity of cells were investigated using
the colorimetric 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium
Bromide (MTT) reduction assay. MTT solution (0.5 mg/ml) (Sigma-
Aldrich Chemie GmbH, Steinheim, Germany #M5655) was adminis-
tered to cells in a 96-well plate format for maximum 1 h. Afterward, the
MTT-containing medium was entirely removed and the plate was in-
cubated for at least 2–4 h at −80 °C. Dimethyl sulfoxide (DMSO)
(Sigma-Aldrich Chemie GmbH, Steinheim, Germany, #D8418, Lot#
SHBH9942) was applied to the cells which allowed the formazan to
uniformly disperse in the solution. DMSO was incubated for 1 h at 37 °C
under continuous shaking conditions. The absorbance values were de-
termined by Synergy™H1 (Bad Friedrichshall, Germany) Hybrid Multi-
Mode Reader at 570 nm with a reference ﬁlter at 630 nm. Untreated
healthy cells, deﬁned as controls, were regarded as 100% cell viability.
We dissolved the linalool in DMSO 0.1%, and this solvent had no eﬀect
on cellular activity or metabolic activity. HT-22 cells were co-treated
with linalool or glutamate seeded onto 96 well plates in conditions as
follows: control condition, linalool 100 μM, glutamate 6mM and co-
treatment with glutamate 6mM plus linalool 100 μM.
Cell viability was measured in real-time using the xCELLigence
®RTCA MP system (ACEA BIO, The Netherlands) which is a label-free
cell-based assay suitable for continuous monitoring of biological pro-
cesses of living cells [29]. Continuous cell monitoring was performed
using an E-plate 96 and measured by the xCELLigence ®RTCA MP In-
strument. Cellular impedance was assessed every 30min for 24 h and
represented as Normalized Cell Index (NCI) which was deﬁned before
the application of the experimental conditions (control, linalool 100
μM, glutamate 6mM and co-treatment of glutamate 6mM with linalool
100 μM) as the starting point (t: 0 h) of the experiment.
2.3. Flow cytometry
Several intracellular parameters associated with oxidative stress,
mitochondrial dysfunction, and cell death were determined by ﬂow
cytometry analysis using the CytoFLEXS benchtop ﬂow cytometer
(Beckman Coulter Life Sciences, Indianapolis, USA). HT-22 cells were
seeded in 24-well plates with 40,000 cells/well. To allow the compar-
ison between diﬀerent treatment groups (control condition, linalool
100 μM, glutamate 6mM, and co-treatment of glutamate 6mM with
linalool 100 μM) and the total amount of cells per condition. The su-
pernatant of the medium was collected and washed with PBS, followed
by trypsinization. For every condition, three wells were analyzed and
the same number of cells (10,000)/well was counted by ﬂow cytometry.
Minimum of 3 independent experiments were performed, and the
quantiﬁcation of data was acquired using Kaluza Analysis 1.5 software.
2.3.1. Annexin V/PI
In order to assess the amount of apoptotic as well as necrotic cells
after stimulation, Annexin V FITC and propidium iodide (PI)
(Invitrogen, Oregon, USA, #V13242, Lot#2008168) double staining kit
was used. After treatment, HT-22 cells were trypsinized, and the cell
suspension was incubated with Annexin V FITC and PI in binding buﬀer
for 10min at room temperature (RT). Detection of ﬂuorescence was
acquired at FITC: 494/518 and PI: 535/617.
2.3.2. Mitochondrial ROS production
Mitochondrial ROS formation was evaluated by the MitoSOX dye
(Invitrogen, Oregon, USA, #M36008, Lot#1924466). HT-22 cells were
incubated with MitoSOX™ 1.25 μM dye for 30min at 37 °C.
Fluorescence was excited at 488 nm and detected at 690/50 nm.
2.3.3. Mitochondrial membrane potential
Loss of mitochondrial membrane potential (ΔΨm) was determined
by staining with TMRE™ dye (tetramethylrhodamine-ethyl ester;
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Invitrogen, Oregon, USA, #T669). Cells were collected and incubated
for 20min with TMRE 0.2 μM at 37 °C. Fluorescence was excited at
488 nm and detected at 690/50 nm.
2.3.4. Measurement of mitochondrial calcium
For the measurement of mitochondrial calcium levels, HT-22 cells
were incubated with of rhodamine-2-acetoxymethylester 2 μM dye
(Rho2-AM) (Abcam, #ab142780, Lot# APN15176-1-1) in DMEM
without serum for 30min at RT, followed by incubation in DMEM for
30min at RT in the dark and washed with PBS. Cells were excited at
552 nm wavelength and the emission intensities at 581 nm.
2.3.5. Lipid peroxidation
Lipid peroxidation was estimated with BODIPY 2 μM staining dye
(Invitrogen, Karlsruhe, Germany, #D3861, Lot# 1890330) for 60min
at 37 °C. Cells were washed once with PBS followed by their analysis
using the excitation channel at 488 nm and detection channel at
530 nm.
2.4. Mitochondrial morphology: Mito Tracker deep red
HT-22 cells (4× 104 cells) were treated with diﬀerent conditions
(control condition, linalool 100 μM, glutamate 6mM and co-treatment
of glutamate 6mM with linalool 100 μM) for 18 h and incubated with
200 nM MitoTracker™Deep Red FM (Invitrogen, Oregon, USA,
#M22426, Lot# 509441) for 30min at 37 °C. After ﬁxation with 4%
Paraformaldehyde (PFA), the ﬂuorescence was excited at 620± nm
and detected at 700 ± 75 nm. 500 cells per condition were counted
and classiﬁed into four diﬀerent categories based on their mitochon-
drial morphology. This categorization was obtained by an investigator
with no prior knowledge of the experimental conditions.
Category I represents healthy cells where mitochondria form an
elongated tubular network distributed equally throughout the cytosol,
Category II represents semi-viable cells comprising short yet tubular
mitochondrial networks around the cytosol. Category II comprises mi-
tochondria that appear short but are still forming long tubules. Cells
which entail large, fragmented/ granulated mitochondria around the
nucleus are referred as Category III. These cells do not show apoptotic
features. On the contrary, damaged and dying cells were identiﬁed by
small rounded mitochondria of diﬀ ;erent sizes within proximity of the
nucleus. The latter mitochondria are referred to as Category IV [30].
Three independent experiments were performed.
2.5. Mitochondrial respiration
HT-22 cells (4–8×107) were harvested and mitochondria were
isolated utilizing semi-automated pump-controlled cell rupture system
(0.71 ml/min) (PCC) using syringes (SGE, Trajan© Scientiﬁc, Australia)
attached to a cell homogenizer (Isobiotech, EMBL Heidelberg,
Germany) superimposed on a pump (ProSense, Oosterhout, NL, #NE-
1000) [31]. Mitochondria were suspended in isolation buﬀ ;er (sucrose
250mM, HEPES 20mM, EDTA 3mM adjusted to pH 7,5). The entire
procedure was performed on ice.
2.5.1. High-resolution respirometry (Oroboros)
The amount of protein derived from the isolation procedure was
250 μg and it was determined using the Pierce™BCA Protein Assay Kit
(Pierce™BCA Protein Assay Kit, Thermo Scientiﬁc, Rockford, USA,
#23225). Mitochondrial respiration, of the organelles obtained from
the HT-22, was analyzed via high-resolution respirometry oxygraph
O2K (Oroboros Systems, Innsbruck, Austria). The isolated mitochondria
prepared as previousely described [31] were treated with linalool 100
μM or ethanol for 25min, followed by Oroboros measurements. Mi-
tochondrial state 1 was monitored under continuous stirring at 750 rpm
in 1ml MiR05 buﬀ ;er (EGTA 0.5mM, MgCl2 3mM, lactobionic acid
60mM, taurine 20mM, KH2PO4 10mM, HEPES 20mM, D-Sucrose
110mM, BSA, essential fatty acid-free1g/L, at 7.4 pH). In order to
perform the oxygen polarography, DatLab software (Oroboros Systems,
Innsbruck, Austria) was implemented to record real-time oxygen ﬂux
per tissue mass (pmol O2.s−1⁎ mg−1) at 37 °C. Non-phosphorylating
respiration (State 2) was assessed by addition of complex-I linked
substrates (5 mM) pyruvate (Sigma-Aldrich Chemie GmbH, Steinheim,
Germany #P-2256), and (2mM) malate (Sigma-Aldrich Chemie GmbH,
Steinheim, Germany, #374318). Thereafter, the oxidative-phosphor-
ylation capacity (OXPHOS, State 3) of complex-I linked activity or basal
respiration was initiated by means of adding saturating concentration
(0.8 mM) of ADP (Sigma-Aldrich Chemie GmbH, Steinheim, Germany,
#A5285). Subsequently, addition of oligomycin 0.1 μM/ml (Sigma-Al-
drich Chemie GmbH, Steinheim, Germany, #O4876) was used to block
Fo of the ATP-synthase, thereby inhibiting proton passage. Besides,
maximal respiration (State 3 u) was assessed by incremental (steps 1
μM) addition of the protonophore carbonyl cyanide 4-(triﬂuor-
omethoxy) phenylhydrazone (FCCP, Sigma-Aldrich Chemie GmbH,
Steinheim, Germany, #C2920). End of measurement by addition of
Sodium dithionite (DTT, Sigma-Aldrich Chemie GmbH, Steinheim,
Germany, #15,795-3) to react with all the oxygen present in the
chamberThe oxygen concentration as well as the initial derivate of the
oxygen concentration which is a derivative of the oxygen consumption
is provided as the O2 slope (pmol ⁎ (mL/s) of raw isolated mitochondria.
The measurements were recorded in intervals (2 s) using instrumental
background correction after calibration of the polarographic oxygen
sensors.
2.5.2. Measurement of cellular oxygen consumption rate (OCR)
Oxygen consumption rate (OCR) was measured using XFe96 extra-
cellular ﬂux analyzer (Seahorse Bioscience, Billerica, MA) with the
mitochondrial stress test as previously described [1]. HT-22 cells were
seeded in XFe96-well cell culture microplate at a density of 10,000 cell/
well and incubated at 37 °C incubator with 5% CO2. 24 h before the
assay, the growth medium was replaced with a new medium containing
linalool 100 μM or 200 μM. Cells were incubated for 1 h in 180 μL of
assay medium (non-buﬀered DMEM) supplemented with 4.5 g/L glu-
cose, 2 mM glutamine and 1mM pyruvate, pH 7.35 in CO2 free in-
cubator at 37 °C. During the assay, basal respiration was measured
before injecting the following inhibitors: oligomycin (4 μM; port A) as
an ATP synthase inhibitor; 2,4-Dinitrophenol (DNP) (Sigma-Aldrich
Chemie GmbH, Steinheim, Germany, #34334) (50 μM; port B) as a
mitochondrial oxidative phosphorylation uncoupler; and rotenone
(Sigma-Aldrich Chemie GmbH, Steinheim, Germany, #R8875) /anti-
mycin A (Sigma-Aldrich Chemie GmbH, Steinheim, Germany, #A8674)
0.1 μM and 1 μM; port C) as complex I and complex III inhibitors. The
OCR measurements were normalized to the protein amount in each well
using BCA assay. Three independent experiments with 6 wells/condi-
tion were performed, and One-way ANOVA test was used to determine
statistical signiﬁcance between diﬀerent groups.
2.6. Animals
C57BL/6 J mice from the central animal laboratory at University of
Groningen were housed and handled in accordance to Dutch standards
and guidelines. All experiments were approved by the University of
Groningen Committee for Animal Experimentation.
2.6.1. Organotypic hippocampal slice cultures and Maintenance
Organotypic hippocampal slice cultures (OHSC) were prepared from
P0-3 mouse pups according to the mentioned protocol with slight
modiﬁcations [32]. Brieﬂy, after quick decapitation, brains were re-
moved and the hippocampi were dissected out in ice cold serum-free
Hank’s Balanced Salt Solution (HBSS) (Sigma-Aldrich Chemie GmbH,
Steinheim, Germany, #14170-088, Lot#1997485), supplemented with
0.5% glucose (Sigma) and 15mM HEPES. Isolated hippocampi were
transversally cut into 350–375 μm thick slices using a McIlwain tissue
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chopper. OHSC were then transferred onto Millcell permeable mem-
branes (0.4 μm pore size, Millipore, PICM03050) in six well plates.
These culture plate inserts, containing 5 to 6 slices with culture
medium: 0.5% Minimum essential medium- MEM (Gibco, #21430-
020,), 25% Basal Medium Eagle (BME) (Gibco, 41010-026), 25% heat-
inactivated horse serum (Gibco, 16050-122) supplemented with 0.65%
glucose (Sigma, G8769) and 2mM glutamax (Gibco, 35050-038), pH:
7.2. OHSC were maintained at 35 °C, 5% CO2 and with culture medium
being changed the ﬁrst day after preparation and every second day.
Experiments were performed after 7–8 days in vitro.
2.6.2. Drug treatment and cell damage in OHSCs
To induce excitotoxicity, OHSCs were exposed to 10 μM N-Methyl-
D-aspartic acid (NMDA) ((Sigma-Aldrich Chemie GmbH, Steinheim,
Germany, #M3262) for 24 h (n:5). At the same time, the OHSCs were
exposed to linalool 100 μM and a combination of NMDA with linalool
100 μM with its respective control. Following 8 days in vitro (DIV8),
slice viability was determined using propidium iodide (PI) staining
(5 μg/ml; Sigma- Aldrich, 81845). PI uptake was recorded using a
Confocal Leica sp8 ﬂuorescence microscope and analyzed by densito-
metry using Fiji-ImageJ software. The 3 main areas of the hippocampus
where the analysis was performed included CA 1 (Cornu Ammonis 1),
CA3 (Cornu Ammonis 3) and DG (Dentate gyrus).
2.6.3. RNA Extraction and quantitative real-time reverse- transcription
polymerase chain reaction (RT-qPCR)
For RNA extraction, 6 OHSC per condition were pooled (one
sample) and incubated in 500 μl using TriReagent (Invitrogen, Life
Technologies, #AM9673) and trimethylene chlorobromide (BCP)
(Sigma-Aldrich Chemie GmbH, Steinheim, Germany, #B9673) followed
by wahing in isopropanol and elution in 30 μl RNAse-free ddH2O (n:4-
6).The concentration and purity of the RNA was determined by mea-
suring absorbance at 230, 160, and 280 nm with a Nanodrop ND-1000
spectrophotometer. Samples were considered to be suﬃciently free of
protein and phenol contamination and suitable for PCR analysis when
the 260/280 and 260/230 ratios were between 1.8 and 2.2.
Total RNA was transcribed into cDNA using reverse transcription by
AMV Reverse Transcriptase Kit (Promega, Madison, WI, #A3500) and
was diluted with ddH2O proportionately according to concentration of
input RNA. RT-qPCR was performed using an iQ5 Real-Time PCR
Detection System (Bio-Rad Laboratories GmbH) in the presence of SYBR
Green (Roche, #04913914001) using Illumina Eco Personal qPCR
System (Westburg, Leusden, The Netherlands). PCR cycling was fol-
lows: 95 °C for 30 s, annealing at 55 °C for 30 s, and extension at 72 °C
for 30 s, for 45 cycles. qRT-PCR data were analyzed with LinRegPCR
analysis software [33]. Geometric mean of the reference genes ribo-
somal protein L13A (Rpl3A) and ribosomal RNA 18S was used to nor-
malize qRT-PCR data. Mouse mRNA primers used in analysis were
purchased from Biolegio and the sequences are listed in Table 1.
2.7. Statistical analysis
Statistical signiﬁcance was evaluated using the unpaired Student´s t-
test or ANOVA and Tukey`s test for post hoc multiple comparisons of
the parametric data in between-group analyses. Non-parametric data
were evaluated using Kruskal- Wallis test. Data were analyzed using
GraphPad Prism software (version 7.0, GraphPad Software Inc., La
Jolla, CA, USA), expressed as mean ± SD for xCELLigence measure-
ments and SEM for the rest experiments. P values indicating statistical
signiﬁcance diﬀerences between mean values are deﬁned as follows:
*p < .05, **p < .01, ***p < .001.
3. Results
3.1. Linalool ameliorated cytotoxicity and apoptosis in glutamate-
stimulated HT-22 cells
Linalool had been reported protective in in vitro models of gluta-
mate-induced excitotoxicity in primary cortical neurons [28]. Here, we
evaluated the eﬀ ;ect of linalool on glutamate-induced oxidative stress
in neuronal HT-22 cells [2]. At ﬁrst, the potential protection against
glutamate-induced oxytosis was assessed using various linalool con-
centrations. Based on the previous experiments, we choose 100 μM
concentration of linalool to investigate the underlying molecular neu-
roprotective mechanisms of linalool. Following the initiation of oxy-
tosis, HT-22 cells change their morphological shape from the healthy
spindle-shaped morphology to a more round-shaped morphology, cul-
minating with the detachment of the cells from the bottom of the cell
culture dish (Fig. 1a, upper panels). The protective eﬀect of linalool was
demonstrated by cell viability measurements using MTT assay fol-
lowing 18 h of glutamate challenge in the presence of linalool. We
observed that glutamate stimulation leads to a signiﬁcant cell death,
whereas co-treatment with linalool in addition to glutamate sign-
iﬁcantly reduces cell death when compared to the glutamate condition.
Application of linalool alone to cells did not signiﬁcantly aﬀect HT-22
cell viability at concentrations of 200 to 400 μM, however, 500 μM
reduced cell viability (Fig. 1.b). Moreover, we observed that linalool at
low nanomolar ranges did not mediate neuroprotection (Figure suppl
1.a). In addition, we performed pre-treatment experiments with 2 h or
8 h of linalool and detected that both pretreatment with linalool for 8 h
and 2 h followed by glutamate challenge provided protection against
glutamate toxicity. Interestingly, the presence of linalool during the
glutamate challenge was a prerequisite for the observed protection,
since the removal of linalool after the pretreatment was not able to
mediate protection against glutamate (Figure suppl 1.b). To further
conﬁrm these neuroprotective eﬀects of linalool, we quantiﬁed cell
death by Annexin V/PI propidium iodide staining. Cells were treated
with glutamate, with or without linalool for 18 h. As shown in Fig. 1.c
and d, the number of double positive stained cells was increased after
glutamate exposure, indicating cell death, and this eﬀect was largely
attenuated by linalool application.
The protective eﬀect of linalool against glutamate toxicity in HT-22
cells was also conﬁrmed by real-time cell impedance measurements
using the xCELLigence system. Cell impedance measurements demon-
strated that glutamate induces a strong decrease in cell index, an in-
dication of cell detachment and cell death, approximately 10–14 h
following the initiation of the glutamate treatment (Fig. 1.e). Co-
treatment with linalool signiﬁcantly delayed cell death, determined by
Table 1
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a right shift of the cell impedance curves. Treatment with linalool alone
did not alter the cell index or morphological shape of the cells. Inter-
estingly, linalool did not prevent cell death when cells were challenged
with erastin instead of glutamate (Figure suppl 1.b). Erastin was shown
to induce ferroptosis cell death and associated with mitochondrial
dysfunction and lipid peroxide formation through iron-dependent oxi-
dative enzymes [10]. Taken together, these results show that linalool is
able to signiﬁcantly reduce glutamate-induced cell death in neuronal
HT-22 cells.
3.2. Linalool preserves mitochondrial integrity in glutamate-treated HT-22
cells
The cell death pathway of oxytosis involves mitochondrial frag-
mentation and dysfunction. Since mitochondrial fragmentation could
be initiated by glutamate [30], we assessed whether linalool could
preserve mitochondrial morphology. First, we identiﬁed changes in
mitochondrial morphology after glutamate exposure compared to
control cells (Fig. 2.a–b). In untreated control cells, mitochondria show
an elongated and tubular-like shape distributed along the cytosol. This
mitochondrial shape is considered as category I and is most frequently
found in healthy cells; while category II mitochondrial networks are less
extensive than category I mitochondria but are still forming long
Fig. 1. Protective eﬀects of linalool against glutamate in HT-22 cells. (a). Representative pictures of the cell morphology of HT-22 cells treated with glutamate
(6mM, 16 h) with and without linalool (100 μM) co-treatment. Magniﬁcation 10x (Scale bar: 100 μm) (b). Representative MTT assay of cells treated with glutamate
and linalool in a range of 100 μM to 500 μM (n=6 technical replicates; independent experiments repeated at least 3 times). (c,d).Measurement of the green Annexin
V and the red PI ﬂuorescence by FACS from HT-22 cells challenged with glutamate (6mM) for 18 h in the absence and presence of linalool co-treatment (10,000 cells
per condition; n= 3 technical replicates; +++p < 0.001:untreated control versus glutamate, ***p < 0.001: glutamate versus linalool+glutamate-treated cells
ANOVA, Tukey’s test, independent experiments repeated at least 3 times). (e). Impedance-based real time detection of the morphological alterations of glutamate-
treated HT-22 cells with and without linalool co-treatment (mean ± SD; n= 6 technical replicates). All experiments were repeated at least three times.
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tubules. However, in cells treated with glutamate, mitochondrial ﬁssion
and fragmentation was elevated and category III and IV are more
abundant. Category III is characterized by round mitochondria spread
throughout the cell and category IV exhibit round and disintegrated
mitochondria surrounding the nucleus. Examination of the acquired
confocal images and their categorization (Fig. 2.a–b) indicated a sign-
iﬁcant diﬀ ;erence between glutamate-treated cells and the remaining
conditions, explicitly pertaining to mitochondrial categorization. HT-22
cells exposed to toxic glutamate showed a signiﬁcant reduction in mi-
tochondria of categories I and II while mitochondria of category IV was
signiﬁcantly increased. In accordance with the cell viability data, co-
treatment of glutamate with linalool showed similar mitochondrial
categories as the control healthy cells, indicating that linalool is able to
preserve mitochondrial shape and prevent its fragmentation.
Under physiological conditions, mitochondria represent the major
endogenous source of ROS as a byproduct of the electron transfer
system (ETS). ROS generation is enhanced upon mitochondrial dys-
function, subsequently leading to oxidative damage to lipids, proteins,
and DNA [34]. We evaluated the mitochondrial ROS levels using ﬂow
cytometry of the ﬂuorescent MitoSOX dye, following glutamate ex-
posure in the presence or absence of linalool. Analysis of the FACS data
indicated that HT-22 cells stimulated with glutamate yielded a sign-
iﬁcant increase in mitochondrial ROS levels when compared to vehicle-
treated cells. HT-22 cells co-treated with glutamate and linalool showed
signiﬁcantly decreased amounts of mitochondrial ROS levels when
compared to the glutamate condition (Fig. 3.a–b).
Next, we evaluated the mitochondrial membrane potential (△ψm)
by FACS analysis of the TMRE ﬂuorescence, a dye speciﬁc for △ψm
measurements. Our results indicated that glutamate challenge provoked
a signiﬁcant decrease in △ψm. Linalool alone did not result in a no-
ticeable diﬀ ;erence compared to vehicle-treated cells (Fig. 3.c–d),
while in the presence of glutamate, it signiﬁcantly alleviated the loss of
△ψm.
Mitochondria play an essential role in buﬀering the cytosolic cal-
cium overload in stimulated neurons. Therefore, we evaluated
Rhod2AM ﬂuorescence, speciﬁc for assessing mitochondrial Ca2+ levels
by FACS measurements. Following glutamate treatment, we observed
an increase in the Rhod2AM ﬂuorescence intensities, while co-treat-
ment with linalool reduced the increase in mitochondrial Ca2+ levels
(Fig. 3.e–f).
3.3. Linalool reduces lipid peroxidation in HT-22 cells
In HT-22 cells, glutamate exposure triggers an increase of detri-
mental ROS levels and also of lipid peroxides. To investigate the
inﬂuence of linalool on lipid peroxide levels under oxidative stress, HT-
22 cells were challenged with glutamate in the presence or absence of
linalool for 18 h. Lipid peroxidation was examined by FACS analysis
Fig. 2. Linalool attenuates mitochondrial fragmentation in glutamate-exposed HT-22 cells. (a). Mitochondrial morphology was classiﬁed into 4 categories of
fragmentation (category I: mitochondria tubulin-like distributed equally throughout the cytosol; category II: short mitochondrial but still forming long tubules;
category III: Large round mitochondria that begin to disrupt; category VI: Small rounded mitochondria of diﬀ ;erent sizes within proximity of the nucleus. (b).
Changes of mitochondrial morphology were visualized following glutamate exposition -challenge (18 h – 6mM) using MitoTracker Red (scale bar: 20 μm). (c).
Quantiﬁcation of mitochondrial categories in all conditions. 500 cells per condition; n=3 independent experiments; mean ± SEM, **p < 0.01: glutamate ver-
suslinalool+glutamate-treated cells ANOVA, Tukey’s test.
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Fig. 3. Linalool preserved mitochondrial integrity. Mitochondrial integrity was analyzed by means of ﬂuorescent-activated cell sorting using ﬂuorescent probes for
(a–b). mitochondrial ROS levels (MitoSOX), (c–d) mitochondrial membrane potential (TMRE) or (e–f) mitochondrial calcium (Rhod2 AM) following glutamate
exposure (18 h) in the presence or absence of linalool 100 μM in HT-22 cells. Data are presented as mean ± SEM, n=3–4 technical replicates, independent
experiments repeated at least 3 times, *p < 0.05, **p < 0.01, ***p < 0.001: glutamate versus linalool + glutamate-treated cells ANOVA, Tukey’s test.
Fig. 4. Lipid peroxidation decreases with exposure of linalool after glutamate treatment. (a). Representative measurements of lipid peroxidation following glutamate
exposure (18 h) in the presence or absence of linalool (Lin) in HT-22 cells. b. Bar graphs with statistics. Results are shown as mean ± SEM, n= 3 technical replicates.
All experiments were repeated at least three times. **p<0.01: glutamate versus linalool+ glutamate-treated cells ANOVA, Tukey’s test.
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using BODIPY ﬂuorescence. Exposure of HT-22 cells to glutamate in-
duced a signiﬁcant increase in lipid peroxidation, while linalool co-
treatment was able to reduce the lipid peroxidation. Additionally,
treatment with linalool-only was unable to produce a signiﬁcant in-
crease of this marker (Fig. 4.a–b). Taken together, linalool application
enhanced protection against glutamate-induced oxidative toxicity by
preserving mitochondrial morphology and reducing the detrimental
levels of mitochondrial ROS, lipid peroxides, and mitochondrial Ca2+.
3.4. Linalool increases mitochondrial respiration in HT-22 cells
Oxidative phosphorylation is a central energy-conserving me-
chanism, coupling mitochondrial electron transfer to ATP synthesis and
providing the energy required for the maintenance of cellular functions
and cell survival [35]. Assessment of mitochondrial respiration re-
presents a functional evaluation of mitochondrial homeostatic state
[36,37]. In the next step, to study alterations of the main mitochondrial
metabolic functions, we performed high-resolution respirometry ex-
periments in puriﬁed mitochondria of HT-22 cells. Interestingly, we
found that linalool application to isolated mitochondria for a period of
25min showed a tendency towards improved complex I-linked re-
spiration rate, induced by ADP (state 3) (Fig. 5.b). Analysis of OXPHOS
in isolated mitochondria from HT-22 revealed that linalool also pro-
motes an increase in maximum uncoupled respiration induced by FCCP
(Fig. 5.a.b).
To complete the characterization of the respiratory capacity of the
mitochondria (depicted as oxygen consumption rate; OCR), we used
Seahorse Bioscience XF96 Extracellular Flux Analyzer. Fig. 5.d.e.
showed an increase in the mitochondrial respiration states, particularly,
in the maximal respiration values as well as the spare respiratory ca-
pacity with the addition of linalool 100 μM to HT-22 cells, when
compared with solvent-treated control cells. This increase in values is
concentration dependent, as linalool 200 μM elicited a higher increase
in respiration levels compared to linalool 100 μM. Considering these
results, linalool improved mitochondrial respiration when compared to
vehicle-treated HT-22 cells and also in isolated mitochondria.
3.5. Linalool signiﬁcantly reduced NMDA-mediated cell death and
cyclooxygenase-2 in organotypic brain slices
In order to corroborate the in vitro data (HT-22 cell line), potential
neuroprotection eﬀects of linalool were also evaluated ex vivo in OHSC.
This ex vivo model is a good method for assessing neuronal death, mi-
croglial activation, neurogenesis, and drug screening. OHSC mainly
preserves tissue structures, maintain neuronal activities and synapse
circuitry, and mimic many aspects of the in vivo context [38]. After six
days in culture, we exposed OHSC to 10 μM NMDA in the presence or
absence of linalool for 24 h (Fig. 6.a). Cell death was measured by
Propidium Iodide (PI) uptake using imaging quantiﬁcation of the hip-
pocampal slices. NMDA stimuli induced a strong increase in PI uptake
in the CA1 and GD regions of the hippocampus, while the CA3 region of
the hippocampus was less aﬀected. Co-treatment with linalool sig-
niﬁcantly reduced the PI uptake in CA1 hippocampal region, although
the NMDA-induced damage of GD and CA3 regions was less aﬀected by
linalool application (Fig. 6.b.c). Concerning apoptosis evaluation, hip-
pocampal slices challenged with NMDA stimuli showed an increase,
Fig. 5. Addition of linalool increases the uncoupled respiration in HT-22 cells. (a). Representative oxygen slope of isolated mitochondria from HT-22 cells. Corrected
oxygen slope showing mitochondrial states after treatment with control (ethanol) or linalool 100 μM. (b–c). Quantiﬁcation of state 3 and state 3 u of mitochondria
pre-treated with control or linalool 100 μM in HT-22 cells (n=3 technical replicates; independent experiments repeated at least 3 times). (d). Oxygen Consumption
Rate (OCR) measurements in HT-22 cells treated with or without linalool 100 and 200 μM were obtained over time (min) using an extracellular ﬂux analyzer
(Seahorse Bioscience). The mitochondrial stress test was used to obtain bioenergetics parameters, by adding substrates (e). Maximal OCR was stimulated by DNP
50 uM addition and the spare respiratory capacity was calculated as the diﬀerence between maximal and basal OCR. Graphs show the OCR in pmoles per min. Data
are shown as mean ± SEM, n= 3–6 technical replicates. All experiments were repeated at least three times. *p<0.05 compared to indicated control.
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although not signiﬁcant to apoptotic Bax protein expression (Fig. 6.d).
To determine if any anti-/pro-inﬂammatory genes of the signaling
systems were involved in the protective eﬀect of linalool on NMDA-
induced excitotoxicity in the hippocampus, we analyzed the expression
of the following genes: Interleukin 1 beta (Il-1β), Nitric Oxide Synthase
2 (Nos2), Tumor necrosis factor alpha (Tnfα) and cyclooxygenase-2
(Cox-2) genes by RT-qPCR. Cox-2 gene expression was increased after
NMDA treatment and treatment with linalool reversed this proin-
ﬂammatory marker to levels similar to the controls (Fig. 6.d). Nos2 gene
expression seems to increase, albeit no signiﬁcant values were detected
following NMDA treatment, while co-treatment of linalool showed a
tendency to decrease the levels of Nos2 genes. Il-1β and Tnfα did not
show any diﬀerences between the treatments (Fig. 6.d). However,
NMDA challenge of OHSC did signiﬁcantly increase Cox-2 levels when
compared to OHSC-vehicle conditions (post hoc p < 0.01).
Data obtained in OHSC cultures validated the neuroprotective ef-
fects of linalool detected in neuronal HT-22 cell line. Furthermore, our
results reinforce the hypothesis where the mitochondria are involved in
the mechanism of protection when is activated by this monoterpene.
4. Discussion
Our ﬁndings demonstrate a neuroprotective eﬀect of linalool in
conditions of oxidative stress through mechanisms involving an in-
crease in mitochondrial respiration, and preservation of several mi-
tochondrial parameters, including ROS, calcium levels, and △ψm.
Furthermore, linalool mediated protection against NMDA-induced ex-
citotoxicity in hippocampal slices. Taken together, we showed that li-
nalool induced neuroprotective eﬀects in an in vitro and ex vivo models
by preserving and restoring mitochondrial function.
In this study, we showed that linalool improves the viability of
neuronal cells by 30% in conditions of oxidative stress, independent of
excitotoxicity. The in vitro model of oxytosis was employed in neuronal
HT-22 cells, which lack the NMDAR, therefore, glutamate stimulation
initiates a distinct pathway of cell death independent of NMDA-related
increased neuronal excitability [5]. In this paper, we determined the
potential timeframe of linalool’s protection, which was detected fol-
lowing 10 h of glutamate challenge and was maintained longer than
24 h. Our results are in line with ﬁndings investigating the eﬀ ;ects of
linalool in glucose/serum deprivation (GSD)-induced cytotoxicity.
Under GSD conditions, linalool was able to exert neuroprotective eﬀects
following 8 h of GSD in PC12 cells [16]. Similarly, in neuronal cultures
has been shown that after oxygen-glucose deprivation/reoxygenation
(OGD/R) or glutamate-mediated excitotoxity as in vitro model of is-
chemic stroke, linalool attenuated cell death. The neuroprotection was
mediated by scavenging peroxyl-radicals, increasing SOD and catalase
levels. We have previously demonstrated the role of linalool in vitro in a
glutamate excitotoxicity model where linalool restored intracellular
ATP levels in neurons and astrocytes [28]. Our results parallel another
research using a diﬀerent monoterpene, catalpol, that was shown to
exert neuroprotection in the hippocampal CA1 area of a gerbil transient
global cerebral ischemia model [39].
Mitochondrial fusion and ﬁssion processes are tightly coordinated
by several dynamin protein family members (e.g. ﬁssion 1, dynamin
related protein 1, endophilin B1), in response to environmental changes
and cellular stress [30,40]. Based on previous research which showed
that glutamate induces mitochondrial damage in HT-22 cells [2,41], we
investigated whether linalool was capable of moderating this eﬀ ;ect.
Our results showed that linalool HT-22 cells prevent damaged or dying
cells (mitochondrial category IV) stimulated with glutamate. Further,
linalool prevented mitochondrial fragmentation and peri-nuclear ac-
cumulation of the organelles providing further evidence of its beneﬁcial
impact on mitochondria. Besides, we investigated the ability of linalool
to modify the mitochondrial membrane potential (△ψm). The latter is
a consequence of the proton gradient which exists across the inner
mitochondrial membrane and is utilized for ADP phosphorylation. The
Fig. 6. The eﬀ ;ect of linalool on NMDA excitotoxicity in mouse OHSCs. (a). Experimental time schedule for treatment with linalool after 10 μM NMDA challenge for
24 h. (b). PI staining images indicating the eﬀects of vehicle, linalool and NMDA alone and NMDA+ linalool on hippocampal cell damage. Magniﬁcation 5x (Scale
bar: 50 μm) (c). PI ﬂuorescence into CA1, CA3 and DG areas of each sample was expressed as % of total PI ﬂuorescence. (d). qPCR analysis of diﬀerent treatments in
slice cultures revealed diﬀerences in the levels of Cox-2 in the NMDA treatment compared with the control. No diﬀerences were observed in Bax, Il-1β, Nos2 and Tnf-
α. Data are shown as mean ± SEM n=4–6 independent experiments). +p < 0.05, ++p < 0.01, +++p < 0.001: untreated control vs NMDA, *p < 0.05:
NMDA versus linalool+NMDA-treated OHSC ANOVA, Tukey’s test.
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net negative charge across a healthy mitochondrion is essentially gen-
erated by cytochrome c, which shuttles electrons along the ETS. How-
ever, this function is impaired during oxytosis which not only leads to
mitochondrial membrane permeabilization but also to release cyto-
chrome c into the cytosol leading to immediate dissipation of△ψm [5].
Our ﬁndings showed that linalool enhanced mitochondrial respiration
and preserved △ψm which might be a consequence of the conserved
inner mitochondrial membrane (IMM).
The brain is particularly susceptible to oxidative stress due to its
high content of unsaturated phospholipids [42]. Oxidative stress is
highly associated with pathological conditions such as AD, in relation to
Aβ plaque burden, and cerebral ischemia, initiated by excessive release
of excitatory neurotransmitters and Ca2+ leading to increased ROS
formation [43,44]. Our results showed co-treatment of glutamate-sti-
mulated HT-22 cells with linalool leads to a reduction of ROS levels.
Previous studies showed that linalool reduced intracellular oxidative
stress in the OGD/R condition [45]. Furthermore, linalool prevented
glutamate-induced cell death alongside retraction of processes and
actin cytoskeleton depolymerization in neurons [28]. However, gluta-
mate-stimulation in HT-22 cells yields a well-deﬁned program of cell
death via oxytosis; therefore, our ﬁndings suggest that the reduction in
ROS levels might be due to an increase of intracellular GSH availability.
The latter is in line with previous research that showed linalool reduced
oxidative stress and the levels of malondialdehyde in an animal model
of neurotoxicity produced by acrylamide increasing the GSH levels
[46].
We reported for the ﬁrst time, the eﬀect of linalool on mitochondrial
respiration in a hippocampal cell line. Mitochondrial respiration is the
power source of eukaryotic cells due to provision of ATP by means of
OXPHOS [47]. We observed an increase in maximal oxygen consump-
tion with linalool. Maximal oxygen consumption rate attained by
adding the uncoupler FCCP. FCCP mimics a physiological “energy de-
mand” by stimulating the respiratory chain to operate at maximum
capacity, which causes rapid oxidation of substrates to meet this me-
tabolic challenge [48]. This indicates that increased maximal respira-
tion and spare capacity is associated with increased metabolic ﬁtness as
it makes the cell better able to cope with stress. There are few studies
about monoterpenes involved in complex of mitochondrial respiration.
It has been described by Usta et al., 2009 that linalool reduced cell
viability of cancer cells (HepG2) by inhibition of complexes I and II and
decreasing ATP [49]. Other monoterpenes as β-Pinene showed un-
coupling eﬀects at lower concentrations (100–200 μM) than the in-
hibition of respiration (400 μM) through an eﬀect on the electron
transport chain in the liver of Wistar rats [50]. In addition, a combi-
nation of monoterpenes camphene and geraniol (1:1) protected against
nimesulide hepatotoxicity in vivo, reducing the mitochondrial swelling,
inhibition in release of apoptotic proteins and prevented mitochondrial
depolarization along with reduction in oxidized NAD(P)H and in-
creased mitochondrial electron ﬂow [51]. These ﬁndings demonstrated
that monoterpenes have a potential to regulate mitochondrial respira-
tion in diﬀerent disease models.
To validate in vitro data, we evaluated the eﬀects of linalool in
OHSC. We observed an increase in cell death on response to NMDA.
Linalool was found to protect areas in the hippocampus such as CA1,
however, we did not detect signiﬁcant diﬀerences between other re-
gions of hippocampus due to the variability of cell damage.
Additionally, we evaluated genes involved in inﬂammation and cell
death which seemed to increase in response to NMDA. Cox-2 is usually
expressed at low levels under normal conditions, but is rapidly induced
by an injury, triggers pro-inﬂammatory response with prostaglandins
and can worsen neuronal degeneration in neurological diseases such as
stroke [52,53]. We detected a signiﬁcant increase in Cox-2 gene ex-
pression after NMDA treatment while linalool reduced this increase. In
previous research, we observed a reduction in the levels of in-
ﬂammatory markers such as p38 MAPK and Cox-2 after linalool treat-
ment for 3 months in aged 3xTg-AD mice [27]. Similarly, reduction of
Cox-2 levels was also observed post-linalool treatment for 1 month in a
global ischemic model [28]. This result is further supported by other
studies such as reduced levels of cyclooxygenases in other neurotoxicity
models when stimulated with linalool and decrease in a dose-dependent
manner in LPS-stimulated macrophages [54,55].
Recent studies have shown that cytokines such as TNF-α, IL-1β, IL-
1α, IFN-γ are synthesized in the CNS and play an important role in
inﬂammation. This release is promoted after glutamate excitotoxicity
[17]. Linalool administered to mice inhibits behavioural nociceptive
responses caused by proinﬂammatory cytokines Il-1β and TNF-α via
inhibition of NMDA receptors [17,25]. However, we did not ﬁnd any
signiﬁcant increase of these proinﬂammatory cytokines (NO2, IL-1β,
TNF-α) due to variability in the cell damage in the hippocampus.
We have previously described the protective eﬀects of linalool in a
3xTg-AD mice [27] and in cerebral ischemia [28]. Besides, linalool
protects against acrylamide (ACR)-induced neurotoxicity in Wistar rats
decreasing the ACR-induced lipid peroxidation in rat brain tissue [46].
Linalool protection can by mediated by the regulation of glutamatergic
system [56,57], and axonal regeneration [58], among other properties
described in mentioned literature.
5. Conclusion
Our results illustrate that linalool positively impacts the mitochon-
drial functioning of glutamate-stimulated HT-22 cells. We observed li-
nalool reduced ROS, calcium production, and lipid peroxidation levels.
Additionally, improved mitochondrial morphology, membrane poten-
tial, and respiration. This together results in an increase of cell viability.
Importantly, this study is among the ﬁrst to elucidate the particular
underlying mechanism by which linalool exerts its eﬀ ;ectiveness,
precisely via a protective impact on the mitochondria. We validate the
in vitro neuroprotective data with ex vivo OHSC slices where we showed
a reduction of cell death in the hippocampus and modulation of various
genes by linalool. Our data indicate that linalool may be therapeutically
useful in treating neurodegenerative conditions marked by mitochon-
drial dysfunction and subsequent ROS production, due to its beneﬁcial
impact on mitochondrial integrity as well as ability to limit oxidative
stress.
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